CGT Asia 2026(Shanghai Railway Station）

We are in an era of breakthroughs in biomedicine. Cell and gene therapy, as disruptive frontier fields, are turning many previously "incurable" diseases into possibilities. It no longer merely aims to alleviate 

symptoms but is dedicated to correcting diseases at their root, representing a paradigm shift in the global pharmaceutical industry from "molecular drugs" to "living drugs". 

Years of dedication have led to remarkable achievements. Since the first summit set sail, CGT Asia has been in harmony with the industry, fortunate to witness and contribute to the vigorous development 

of the CGT field in Asia. Standing at this milestone of the 10th edition, which marks both a continuation and a new beginning, the "10th CGT Asia 2026 Summit on Cell and Gene Therapy Innovation" hosted 

by TanSi Biotech will be grandly held in Shanghai from April 1st to 2nd, 2026.

Partial data of CGT Asia 2025 event (unit: percentage %)

This conference will deeply focus on the latest developments in cell and gene drug research, analyzing the trends and integration applications of core technologies such as immune cell therapy, gene therapy for rare diseases, gene editing, in vivo CAR-T technology, mesenchymal stem cells, and AAV vectors, and accelerating the transition of innovative therapies from the laboratory to practical use. In addition, the summit will bring together top scientists, clinical researchers, business leaders and policy experts from Asia, jointly outlining the development path and commercial future of cell and gene therapy in the next stage.